Business Wire

CHTF2019 Kicks off in Shenzhen, Gathering Global Exhibitors and Visitors

Share

China’s No. 1 technology show – the 21st China Hi-Tech Fair (CHTF2019) – opened at the Shenzhen Convention and Exhibition Center on November 13, and will run till November 17.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191113005440/en/

Themed on "Invigorating the Greater Bay Area through Opening-up and Innovation," CHTF2019 is expected to attract more than 3,300 exhibitors from home and abroad, as well as over 500,000 visitors coming from over 100 countries and regions.

This year, CHTF arranged 5 key routes for visitors: The Greater Bay route, 5G route, smart manufacturing route, gadget route and the investment potential route. The event will cover every sector of the hi-tech industry including artificial intelligence, smart home, smart manufacturing, Internet of Things, smart driving, 5G, folding screen mobile phones, etc.

CHTF2019 will witness an increased number and diversity of exhibitors. 44 countries and international organizations will send delegations to participate in the event, setting a new high.

Apart from hi-tech giants such as Huawei, ZTE, Han's Laser, Shenzhen China Star Optoelectronics Technology Co Ltd, and NTT Data, a batch of newly-started companies with high value, including Cambricon and Orbbec, will also showcase their products during CHTF.

Su Yanwei, Deputy Director of CHTF Organizing Committee, said, “This year, we will gather more than 3,000 companies, 200 institutions, 100 universities, as well as over 20 innovation centers.”

Wang Lixin, Deputy Mayor of Shenzhen, said, “With four decades of development, Shenzhen has grown into a center of China's hi-tech industry. Shenzhen should play a key role in the construction of the international science and technology innovation center in the Greater Bay Area that encompasses Guangdong, Hong Kong and Macao.”

In addition, during the China Hi-Tech Forum, which is held concurrently with CHTF, more than 250 sub-forums will be held, gathering around 70 world renowned speakers and guests including Turing Award winner Joseph Sifakiswill, Father of Industry 4.0 Dr. Christoph Meinel, and Nobel Prize laureate Erwin Neher.

During CHTF 2019, a group of major innovation projects will be nailed down in Shenzhen, including the big data and artificial intelligence lab co-built by Shenzhen Longgang District's bureau for administrative services data and Peng Cheng Laboratory.

Contact information

Ms. Peggie Wang
China Hi-Tech Fair Organizing Committee Office
Tel.: +86-755-82848962, Email: wangyq@chtf.com, 654333235@qq.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BearingPoint helps government and public sector organizations deliver critical health and public services during the Covid-19 pandemic6.7.2020 10:00:00 EESTPress release

Management and technology consultancy BearingPoint announced today that it is helping its government and public sector clients across Europe to deliver critical health and public services during the Covid-19 pandemic through new delivery models, new ways of working, digitalization, and automation. “BearingPoint’s organization as a single, European-based business has meant we have been able to draw on capabilities, leading practices and learnings from across our government and public sector clients and teams in many different countries. Working remotely and in partnership with our clients, we have quickly mobilized resources to design and deliver solutions to support both the public services needed during Covid-19 and the new ways of working for public servants,” said Andrew Montgomery, Partner and Global Leader Government and Public Sector at BearingPoint. New delivery models and services People’s health and well-being during the Covid-19 crisis have required public services to rapidly

DNA Selects VisualOn’s OnStream® Android TV to Deliver the Highest Quality of Service for Their Over the Top (OTT) Deployment on the Android TV Platform6.7.2020 09:00:00 EESTPress release

VisualOn, Inc., a streaming software provider that enables scalable, cross-platform media playback for leading video services, today announced that the company is now providing DNA's end users the ability to stream the highest quality video using the Android TV. DNA is Finland's largest cable operator. Launched in February this year, the new DNA TV has revamped DNA’s TV offering for IP-based delivery, introducing multiple features including unlimited NPVR recordings, a new user interface and improved video stream quality. Through its innovative program-centric approach, subscribers can view and record unlimited TV programs with unprecedented ease of use and watch live and VOD content whenever they want, anywhere in the EU via the DNA TV app. Furthermore, the service delivers compelling content recommendations based on users’ individual viewing preferences. VisualOn, powered by AWS, has closely supported DNA to build and deploy this platform. “Service reliability and a seamless user exp

EMA Validates and Grants Accelerated Assessment for Trastuzumab Deruxtecan for the Treatment of HER2 Positive Metastatic Breast Cancer6.7.2020 09:00:00 EESTPress release

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for trastuzumab deruxtecan, a HER2 directed antibody drug conjugate (ADC), for the treatment of adults with unresectable or metastatic HER2 positive breast cancer who have received two or more prior anti-HER2 based regimens. Trastuzumab deruxtecan was granted accelerated assessment by the EMA’s Committee for Medicinal Products for Human Use (CHMP). Validation confirms that the application is complete and commences the scientific review process by the EMA’s CHMP. Accelerated assessment is granted by the CHMP to products expected to be of major interest for public health and therapeutic innovation and can significantly reduce the review timelines. “The accelerated assessment highlights the significant unmet need for patients with HER2 positive metastatic breast cancer that trastuzumab deruxtecan aims at addressing

Excelya Welcomes Three European Contract Research Organizations to Become One Stop Provider Throughout Europe6.7.2020 09:00:00 EESTPress release

Today, Excelya, a leading contract research organization (CRO) specializing in clinical research, announced that three European CROs joined Excelya Group: Zeincro based in Central-Eastern & Southern Europe, The Clinical Company based in the Netherlands and Belgium and Koehler eClinical based in Germany. Together, they will be known as Excelya Group. This alliance will allow Excelya to offer a one stop provider service model throughout Europe for its clients, whether they need full service, functional service providing or consulting services. Zeincro is a leading contract research organization primarily operating in Central-Eastern & Southern Europe with particular expertise in clinical operations, safety and medical affairs. The Clinical Company is present in the Belgian and Dutch markets specializing in clinical operations. Koehler eClinical is a German specialty CRO with a focus on biostatistics and data solutions. Thanks to the unification with these three companies, Excelya Group i

Study Investigates Accuracy of Respiration Rate Obtained From Pulse Oximetry on Pediatric Patients Using Masimo RRp®6.7.2020 09:00:00 EESTPress release

Masimo (NASDAQ: MASI) today announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp® on pediatric patients with the Rad-G™ Pulse Oximeter by comparing it to clinician-determined values while performing routine assessment of children admitted to outpatient and emergency departments.1 RRp provides respiration rate determined from the photoplethysmograph used in pulse oximetry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200705005031/en/ Masimo Rad-G™ with RRp® (Photo: Business Wire) Noting the high incidence of childhood pneumonia in many parts of the world, the inclusion of oxygen saturation (SpO2) and respiratory rate measurement in pneumonia screening guidelines, and the scarcity of medical equipment and variability in medical training in many low-resource settings, Dr. Alwadhi and colleagues sought to determine whether a “multi

Kepler Cheuvreux Initiates Coverage of Carbios6.7.2020 07:45:00 EESTPress release

Regulatory News: CARBIOS (Euronext Growth Paris: ALCRB), a company pioneering new bio-industrial solutions to reinvent the lifecycle of plastic and textile polymers, today announces the publication of an initiation coverage report by Kepler Cheuvreux, a leading independent European financial services company specialized in research, execution and advisory services. Carbios is also covered by Bryan, Garnier & Co, Gilbert Dupont and Edison Investment Research. The research report entitled “zero-waste pioneer” released on June 23, 2020 by Kepler Cheuvreux is available on the website www.keplercheuvreux.com under “Research Public Access”. About Carbios: Carbios is a green chemistry company whose innovations help address the environmental and sustainable development challenges facing manufacturers. Since its creation in 2011 by Truffle Capital, the Company has developed, through biotechnology, two industrial processes that revolutionize the biodegradation and recycling of polymers. These in

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom